The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular ...

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendynetm transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease.

The Tendyne system is designated for those who are at high risk for traditional open-heart surgery. It helps with those with ...

Progress with transcatheter tricuspid valve replacement (TTVR) candidate devices Topaz, LuX-Valve Plus, VDyne, and Trisol for ...

CHRISTUS Santa Rosa Hospital — New Braunfels offers a minimally invasive heart valve procedure called transcatheter mitral valve repair, or MitraClip which can serve as an alternative option to ...

Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves (MHV)—and the one designed in their own lab appears to outperform the others.